Drug Research

Palladio Biosciences announced that it has acquired global rights to lixivaptan from Chiesi USA to  develop it for Polycystic Kidney Disease (PKD), an orphan kidney disease for which…
Read More...

Nektar Therapeutics announced that Takeda signed the research collaboration agreement with Nektar Therapeutics through its wholly-owned subsidiary, Millennium Pharmaceuticals to enter…
Read More...

Pharmadax announced that U.S. FDA has approved the generic equivalent of Seroquel XR (quetiapine fumarate) ER tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg, launched by Pharmadex in…
Read More...

MSD President, Jannie Oosthuizen and Astellas Pharma President and CEO, Yoshihiko Hatanaka together announced that MSD has submitted an application for marketing approval of a…
Read More...

The U.S. FDA has expanded approved use of Vertex Pharmaceuticals manufactured Kalydeco (ivacaftor) for treating cystic fibrosis. The approval triples the number of rare gene mutations…
Read More...

The U.S. FDA has granted Octapharma with orphan drug designation for Octagam 10%. Octagam 10% is an immune globulin intravenous (human) liquid for the treatment of…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that USFDA has approved to launch Doxorubicin Hydrochloride Liposome Injection for intravenous use, in the US market. The approval is an outcome…
Read More...

Saneca Pharma announced that after an inspection Russian Federal State Institution ‘State Institute of Drugs and Good Practices’ has granted them multi-dosage cGMP certificate. cGMP…
Read More...

MilliporeSigma announced that SystImmune has selected its CHOZN Expression System for commercial development of a bi-specific antibody therapeutic. The CHOZN expression system is…
Read More...

Pfizer announced that its 13-valent Pneumococcal Conjugate (PCV13) Vaccine has been selected for immunization program of India’s babies in select states. Results of the…
Read More...

Proteon Therapeutics announced that FDA has awarded Breakthrough Therapy Designation to vonapanitase (investigational treatment) for increasing arteriovenous fistula secondary patency…
Read More...

Takeda Pharmaceutical signed contract with GammaDelta Therapeutics for collaboration to develop GammaDelta Therapeutics' novel T cell platform based on the unique properties of gamma…
Read More...

ANI Pharmaceuticals, Inc. announced the launch of its first Pindolol Tablets, 5mg and 10mg. ANI's President and CEO, Arthur S. Przybyl said that they are excited to launch the first…
Read More...

Crown Bioscience announced collaboration with Jiangsu Qyun Bio-Pharmaceutical to develop antibody. The goal of the collaboration is to develop a less toxic CTLA-4 antibody and better…
Read More...

AstraZeneca announced that it entered a strategic collaboration worth $2.1 billion with Pieris Pharmaceuticals to develop novel inhaled drugs that leverage Pieris’ Anticalin platform.…
Read More...

Quivive has entered into service agreements with Camargo Pharmaceutical Services. Camargo will be providing regulatory consulting and strategic development services for Quivive's…
Read More...

Vivet Therapeutics announced that it has recieved €37.5 million in a Series A financing round for advancement in developing gene therapies for treatment of rare inherited metabolic…
Read More...

AMRI announced it received a 5-year federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), for…
Read More...

Verastem focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, today announced the appointment of Eric K. Rowinsky, MD to its Board…
Read More...

Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces that it has initiated…
Read More...